WHO ICTRP trial
Prospective randomized trial of angiotensin receptor neprilysin inhibitor…
JPRN-UMIN000046613 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000046613 |
|---|---|
| Public title | Prospective randomized trial of angiotensin receptor neprilysin inhibitor addition after ablation for atrial fibrillation with hypertension |
| Scientific title | Prospective randomized trial of angiotensin receptor neprilysin inhibitor addition after ablation for atrial fibrillation with hypertension - Prospective randomized trial of angiotensin receptor neprilysin inhibitor addition after ablation for atrial fibrillation with hypertension |
| Primary sponsor | Cardiology University Northern Yokohama Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Atrial Fibrillation with hypertension |
| Interventions | In the intervention group, the antihypertensive drug is changed to an angiotensin receptor neprilysin inhibitor (ARNI) after ablation treatment. The control group will continue with conventional antihypertensive drugs after ablation… |
| Registration date | Jan 13, 2022 |
| Target size | 200 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: